These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Comparison of colony-stimulating activities for evaluating in vitro granulomonopoiesis in normal subjects and in patients with myeloid leukemias. López-Karpovitch X; Padrós-Semorile MR; Hurtado-Monroy R; Cárdenas MR; Niesvizky N; Martínez-Sánchez L; Rojas R Rev Invest Clin; 1985; 37(4):323-7. PubMed ID: 3879370 [No Abstract] [Full Text] [Related]
26. A new method for colony formation in vitro by leukemic cells in acute nonlymphocytic leukemia with PHA-stimulated lymphocyte conditioned medium as stimulating factor. Moriyama Y; Koike T; Takahashi M; Sakurai K; Fujiwara M; Takai K; Kishi K; Sakai C; Sanada M; Shibata A Stem Cells (1981); 1982; 2(4):189-202. PubMed ID: 6963001 [TBL] [Abstract][Full Text] [Related]
27. Genetically determined regulators acting on the blast cells of acute myeloblastic leukemia. McCulloch EA; Minden MD; Kelleher C; Miyauchi J; Wang C; Cheng GY Acta Haematol; 1987; 78 Suppl 1():18-25. PubMed ID: 2829486 [TBL] [Abstract][Full Text] [Related]
28. Analysis of leukemic blast growth factor (LBGF) and autocrine secretion of CSF by leukemic blasts. Shibuya T; Okamura S; Niho Y Nihon Ketsueki Gakkai Zasshi; 1987 Dec; 50(8):1578-85. PubMed ID: 3502308 [No Abstract] [Full Text] [Related]
30. Effects of N4-behenoyl-1-beta-D-arabinofuranosylcytosine on blast progenitors of acute myeloblastic leukemia. Nara N; Tohda S; Suzuki T; Nagata K; Yamashita Y; Imai Y; Maruyama Y; Tomiyama J Cancer Res; 1990 Dec; 50(23):7587-92. PubMed ID: 2253209 [TBL] [Abstract][Full Text] [Related]
31. [Leukemic blast colony assay in studies of progenitor cells from acute myeloblastic leukemia and its clinical application]. Motoji T Rinsho Ketsueki; 1992 Sep; 33(9):1111-20. PubMed ID: 1433931 [No Abstract] [Full Text] [Related]
32. [Proliferation and differentiation of leukemic cells in acute myelocytic leukemia]. Nara N Rinsho Byori; 1998 May; 46(5):424-9. PubMed ID: 9627492 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of colony-forming cells from bone marrow of leukemic patients by 3-oxauracil. Reiner P; Mardiak J; Reinerová M; Ujházy V Neoplasma; 1981; 28(5):533-9. PubMed ID: 6947140 [TBL] [Abstract][Full Text] [Related]
35. Comparison of the proliferative activity and sensitivity to cytosine arabinoside of leukemic blast progenitors in acute myeloblastic leukemia at diagnosis and in relapse. Nara N; Tohda S; Suzuki T; Nagata K; Tanikawa S; Imai Y; Tomiyama J; Shiina S Acta Haematol; 1992; 88(1):17-21. PubMed ID: 1414157 [TBL] [Abstract][Full Text] [Related]
36. Relapse of acute myeloblastic leukemia lasting for four years. Production by leukemic cells of colony-stimulating activity and non-production of leukemia-associated inhibitor. Giannoulis N; Reizenstein P; Ost A Acta Med Scand; 1981; 210(1-2):139-43. PubMed ID: 6945794 [TBL] [Abstract][Full Text] [Related]
37. Leukemic hematopoiesis in vitro: acute myeloid leukemia. Löwenberg B; Touw I Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():5-8. PubMed ID: 2653517 [No Abstract] [Full Text] [Related]
38. Heterogeneity in acute myeloblastic leukemia. McCulloch EA; Kelleher CA; Miyauchi J; Wang C; Cheng GY; Minden MD; Curtis JE Leukemia; 1988 Dec; 2(12 Suppl):38S-49S. PubMed ID: 3199879 [TBL] [Abstract][Full Text] [Related]
39. Comparison between normal and leukemic colony-forming cells in vitro. Kubota K; Miura Y Nihon Ketsueki Gakkai Zasshi; 1983 Dec; 46(7):1577-82. PubMed ID: 6586045 [No Abstract] [Full Text] [Related]
40. Systems used to study the nature of the leukemic cell and predict treatment outcome in patients with myeloproliferative disorders. Goldberg J Clin Lab Med; 1990 Dec; 10(4):809-24. PubMed ID: 2272175 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]